Aaquaries Global Industries Limited mulls investment of USD $ 200 Million in Hong Kong & Slovakia.

Hong Kong, Hong Kong SAR, March 5, 2023 (Issuewire.com) – Aaquaries Global Industries Limited, research involved in niche API manufacturing and marketing of pharmaceutical raw material suppliers to leading formulators offering services such as APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. based integrated pharmaceutical company with a leading position in Anti.Drug substance for malaria, drug substance for anticancer, veterinary medicine APIs made the following announcements today: Aquaquaries Global Industries Limited has invested approximately $200 million in property and patent acquisitions to finance long-term investments. The investment will be in the procurement of patent assets in Hong Kong, China and Slovakia, located in Central Europe. Industry experts believe that Aquaries Global Industries Limited plans to invest around $200 million in property and patent acquisitions, setting a benchmark for other companies to follow. Overseas investments in two strategic locations will strengthen Aquaries Global Industries Limited’ annual earnings and bring many opportunities to NCE and NDDS’ complex research and development field.

https://pharmanewsprwire.com/aaquaries-global-industries-limited-mulls-investment-of-usd-200-million-in-hong-kong-slovakia/

announced a $200 million investment in Hong Kong and Slovakia, Dr. Samir Tarim, Managing Director, Private Pharmaceutical Company Aquaries Global Industries Limited Said ” The Board of Directors and management approved a proposal to invest $200 million in property and patent acquisitions, successfully financing long-term investments. The investment will be in the procurement of patent assets in Hong Kong, China and Slovakia. The investment will provide key access to Hong Kong, China and Slovakia located in Central Europe. These countries have huge market potential and greater market access. This investment is in line with our long-term vision of becoming a major player in Hong Kong, China and Slovakia. The company is funded by NBFC in India and has obtained the necessary approvals for investment. The US$200 million investment in the Hong Kong company has patent assets in China and Slovakia, located in Central Europe. Aquaries Global Limited is rated by a US based rating agency Owens Online Co., Ltd. With over 800 core sales and a net worth of 69 billion,

Dr. Austin Dsouza, Executive Director, Aquaries Global Industries Limited “This is Aquaries Global Industries Limited’s landmark investment in Hong Kong and Slovakia, which has been carefully selected considering due diligence and market conditions. improve productivity and support innovative solutions Public procurement of patents and innovation will help countries to spur innovation and recover without undue financial burden Patent filings in Asian economies accounted for more than 66% of global patent filings in 2020. However, 92% of patent filing activity are located in the People’s Republic of China, Japan, and the Republic of Korea.As companies increasingly value resilience over efficiency, procurement becomes central to strategy.It caters to incompatible value owners. , because we are uniquely positioned to coordinate long-term value creation systems that can withstand exogenous shocks, share the load and grow dynamically.”

About Aquaries Global Industries Limited

Aquaries Global Industries LimitedHeadquartered in Mumbai, India, since 2007, focused on the development, manufacture and sale of high quality, affordable process R&D and API manufacturing service providers for the global pharmaceutical industry, the fastest growing One of the growing pharmaceutical companies. It integrates development, regulatory and manufacturing functions with offices in Dubai, Singapore and Hong Kong. Aquaquaries Global Industries Limited offers a wide portfolio of services from APIs for the generics industry to early stage pharmaceutical research and custom synthesis for branded products. Aquaquaries Global Industries Limited is a customer-focused, backward-integrated, world-class developer, manufacturer and trader of Active Pharmaceutical Ingredients (APIs). It works with leading producers of advanced API solutions and adheres to strict operating procedures and current Good Manufacturing Practices (cGMP) and applicable regulatory requirements to gain a sustainable competitive advantage. Independent company of choice with state of the art manufacturing facilities with compliance and reliable supply. Aquaquaries Global Industries markets in over 75 countries in the Middle East, Europe and Africa, with a broad basket of portfolios containing over 300 APIs across multiple therapeutic segments.

media contact

AAQUARIES GLOBAL PTE.exclusive

john.smith@aaquariespharma.com
+85223194867
AAQUARIES GLOBAL PTE. LIMITED 101 CECIL STREET #09-06 TONG ENG BUILDING SINGAPORE 069533
http://www.aaquariespharma.com